William Tai-Wei Ho - 03 Aug 2021 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
President, CEO and CFO, Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
03 Aug 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 16:55:06 UTC
Previous filing
02 Aug 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Conversion of derivative security +3,070 +4.4% 72,999 03 Aug 2021 By child F1
holding INAB Common Stock 2,289,430 03 Aug 2021 Direct
holding INAB Common Stock 73,000 03 Aug 2021 By child
holding INAB Common Stock 36,500 03 Aug 2021 See footnote F2
holding INAB Common Stock 36,500 03 Aug 2021 See footnote F2
holding INAB Common Stock 36,500 03 Aug 2021 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Preferred Stock Conversion of derivative security $0 -2,792 -100% $0.000000* 0 03 Aug 2021 Common Stock 3,070 By child F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
F2 The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.